Great Lakes Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.72M | Sell |
|
|||||
|
2025
Q2 | $5.19M | Sell |
|
|||||
|
2025
Q1 | $5.84M | Sell |
|
|||||
|
2024
Q4 | $4.46M | Sell |
|
|||||
|
2024
Q3 | $7.07M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $8.93M | Sell |
|
|||||
|
2022
Q1 | $12.2M | Sell |
|
|||||
|
2021
Q4 | $11.8M | Sell |
|
|||||
|
2021
Q3 | $11.3M | Sell |
|
|||||
|
2021
Q2 | $12.6M | Sell |
|
|||||
|
2021
Q1 | $15.1M | Buy |
|
|||||
|
2020
Q4 | $11.9M | Sell |
|
|||||
|
2020
Q3 | $12.5M | Buy |
|
|||||
|
2020
Q2 | $9.27M | Buy |
|
|||||
|
2020
Q1 | $5.5M | Sell |
|
|||||
|
2019
Q4 | $7.44M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $4.58M | Buy |
|
|||||
|
2017
Q2 | $5.33M | Sell |
|
|||||
|
2017
Q1 | $5.17M | Buy |
|
|||||
|
2016
Q4 | $2.09M | Sell |
|
|||||
|
2016
Q3 | $2.23M | Buy |
|